A decreased rate of cell proliferation might indeed explain the less aggressive phenotypes frequently observed in FGFR3-mutated bladder carcinomas, in comparison with EGFR over-expression cases. The gene discussed is FGFR3; the disease is urinary bladder carcinoma.